BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36277293)

  • 1. Multimodality imaging differentiation of pancreatic neuroendocrine tumors and solid pseudopapillary tumors with a nomogram model: A large single-center study.
    Hu HF; Li Z; Chen K; Liu MQ; Ye Z; Chen XM; Zhang Y; Yu XJ; Xu XW; Ji SR
    Front Surg; 2022; 9():970178. PubMed ID: 36277293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of solid-pseudopapillary tumors of the pancreas from pancreatic neuroendocrine tumors by using endoscopic ultrasound.
    Liu Y; Shi S; Hua J; Xu J; Zhang B; Liu J; Yang XJ; Yu XJ
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):947-953. PubMed ID: 32144073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid pseudopapillary tumour should be part of differential diagnosis of focal pancreatic lesions with increased
    Somme F; Montaz-Rosset MS; Averous G; Deur J; Goichot B; Bachellier P; Addeo P; Imperiale A
    Clin Endocrinol (Oxf); 2020 Jul; 93(1):78-81. PubMed ID: 32314437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis between pancreatic solid pseudopapillary tumors and pancreatic neuroendocrine tumors based on contrast enhanced ultrasound imaging features.
    Zhang Q; Qiu YJ; Yang DH; Lu XY; Chen S; Dong Y; Wang WP
    Clin Hemorheol Microcirc; 2023; 85(4):421-431. PubMed ID: 37718786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
    Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-hyperfunctioning pancreatic endocrine tumors: multimodality imaging features with histopathological correlation.
    Humphrey PE; Alessandrino F; Bellizzi AM; Mortele KJ
    Abdom Imaging; 2015 Oct; 40(7):2398-410. PubMed ID: 25989932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and predictive factors of endoscopic ultrasound-guided ethanol ablation in benign solid pancreatic tumors.
    Choi JH; Paik WH; Lee SH; Lee MW; Cho IR; Ryu JK; Kim YT
    Surg Endosc; 2023 Aug; 37(8):5960-5968. PubMed ID: 37079095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptomatic versus symptomatic solid pseudopapillary tumors of the pancreas: clinical and MDCT manifestations.
    Hu S; Zhang H; Wang X; Sun Z; Ge Y; Yan G; Zhao C; Chen K
    Cancer Imaging; 2019 Mar; 19(1):13. PubMed ID: 30845987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI-based radiomics approach for differentiation of hypovascular non-functional pancreatic neuroendocrine tumors and solid pseudopapillary neoplasms of the pancreas.
    Song T; Zhang QW; Duan SF; Bian Y; Hao Q; Xing PY; Wang TG; Chen LG; Ma C; Lu JP
    BMC Med Imaging; 2021 Feb; 21(1):36. PubMed ID: 33622277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of (68)Ga-DOTATOC PET/CT in screening for pancreatic neuroendocrine tumour in patients with von Hippel-Lindau disease.
    Prasad V; Tiling N; Denecke T; Brenner W; Plöckinger U
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2014-20. PubMed ID: 27293206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential value of EUS in pancreatic surveillance of VHL patients.
    van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Koopmans KP; Kema IP; Zonnenberg BA; Timmers HJ; de Herder WW; Sluiter WJ; de Vries EG; Links TP
    Eur J Endocrinol; 2016 May; 174(5):611-20. PubMed ID: 26884551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small (Baek JH; Lee JM; Kim SH; Kim SJ; Kim SH; Lee JY; Han JK; Choi BI
    Radiology; 2010 Oct; 257(1):97-106. PubMed ID: 20663966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Differentiation of Pancreatic Neuroendocrine Tumor From Other Neoplastic Solid Pancreatic Lesions During Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
    Krishna SG; Bhattacharya A; Li F; Ross WA; Ladha H; Porter K; Atiq M; Bhutani MS; Lee JH
    Pancreas; 2016 Mar; 45(3):394-400. PubMed ID: 26418912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT.
    Majala S; Seppänen H; Kemppainen J; Sundström J; Schalin-Jäntti C; Gullichsen R; Schildt J; Mustonen H; Vesterinen T; Arola J; Kauhanen S
    EJNMMI Res; 2019 Dec; 9(1):116. PubMed ID: 31872324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of endoscopic ultrasound (EUS)/endoscopic ultrasound--fine needle aspiration (EUS-FNA) cytology in solid and cystic pancreatic neuroendocrine tumours.
    Mitra V; Nayar MK; Leeds JS; Wadehra V; Haugk B; Scott J; Charnley RM; Oppong KW
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):69-75. PubMed ID: 25822436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
    Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
    Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
    van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Kema IP; Koopmans KP; Valk GD; Timmers HJ; de Herder WW; Feelders RA; Fockens P; Sluiter WJ; de Vries EG; Links TP
    Gastrointest Endosc; 2015 Jan; 81(1):159-167.e2. PubMed ID: 25527055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.
    Morgat C; Vélayoudom-Céphise FL; Schwartz P; Guyot M; Gaye D; Vimont D; Schulz J; Mazère J; Nunes ML; Smith D; Hindié E; Fernandez P; Tabarin A
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1258-66. PubMed ID: 26819103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic Ultrasound Features of Multiple Endocrine Neoplasia Type 1-Related versus Sporadic Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Study.
    Tamagno G; Scherer V; Caimo A; Bergmann SR; Kann PH
    Digestion; 2018; 98(2):112-118. PubMed ID: 29698969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.